Details for New Drug Application (NDA): 206119
✉ Email this page to a colleague
The generic ingredient in TOLVAPTAN is tolvaptan. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the tolvaptan profile page.
Summary for 206119
Tradename: | TOLVAPTAN |
Applicant: | Endo Operations |
Ingredient: | tolvaptan |
Patents: | 0 |
Pharmacology for NDA: 206119
Mechanism of Action | Vasopressin V2 Receptor Antagonists |
Suppliers and Packaging for NDA: 206119
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TOLVAPTAN | tolvaptan | TABLET;ORAL | 206119 | ANDA | Endo USA, Inc. | 49884-768 | 49884-768-54 | 1 BLISTER PACK in 1 CARTON (49884-768-54) / 10 TABLET in 1 BLISTER PACK (49884-768-52) |
TOLVAPTAN | tolvaptan | TABLET;ORAL | 206119 | ANDA | Endo USA, Inc. | 49884-770 | 49884-770-54 | 1 BLISTER PACK in 1 CARTON (49884-770-54) / 10 TABLET in 1 BLISTER PACK (49884-770-52) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
Approval Date: | Feb 15, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 30MG | ||||
Approval Date: | Feb 15, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription